ArticleAntibodies (Basel, Switzerland)2024
A High-Affinity Monoclonal Antibody Against the Pancreatic Ductal Adenocarcinoma Target, Anterior Gradient-2 (AGR2/PDIA17).
Reeder M Robinson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.